By physician referral or invitation only

VACCINE EFFECTIVENESS OF 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST VACCINE-TYPE CAP USING A TEST-NEGATIVE DESIGN

The purpose of this study is to determine the effectiveness of the pneumococcal vaccine (20vPnC) against community-acquired pneumonia.

Age & Gender

65 years ~ 99 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Anne Lachiewicz
Family Medicine

Study Type

Clinical or Medical
Observational

Study Topics

Immune System/Infections

IRB Number

22-2388

ClinicalTrials.gov

NCT05452941

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.